Home Cart Sign in  
Chemical Structure| 1431303-72-8 Chemical Structure| 1431303-72-8

Structure of Iadademstat 2HCl
CAS No.: 1431303-72-8

Chemical Structure| 1431303-72-8

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

ORY-1001 trans is a selective irreversible lysine (K)-specific demethylase 1A (KDM1A/LSD1) inhibitor.

Synonyms: ORY-1001 dihydrochloride; RG6016 dihydrochloride; RO 7051790 dihydrochloride

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Iadademstat 2HCl

CAS No. :1431303-72-8
Formula : C15H24Cl2N2
M.W : 303.27
SMILES Code : N[C@@H]1CC[C@](N[C@H]2[C@H](C3=CC=CC=C3)C2)([H])CC1.[H]Cl.[H]Cl
Synonyms :
ORY-1001 dihydrochloride; RG6016 dihydrochloride; RO 7051790 dihydrochloride
MDL No. :N/A

Safety of Iadademstat 2HCl

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319-H335
Precautionary Statements:P261-P264-P270-P271-P280-P301+P312-P302+P352-P304+P340-P305+P351+P338-P330-P332+P313-P337+P313-P362-P403+P233-P405-P501

Related Pathways of Iadademstat 2HCl

epigenetics

Isoform Comparison

Biological Activity

In Vitro:

Cell Line
Concentration Treated Time Description References
NCI-H510A 0.002 to 2000 nM 10 days Evaluate the effect of Iadademstat on NCI-H510A cell viability, EC50= 0.16 nM ACS Pharmacol Transl Sci. 2021 Nov 12;4(6):1818-1834
THP-1 0.02 to 2000 nM 96 hours Evaluate CD11b protein levels, Iadademstat significantly induced CD11b expression ACS Pharmacol Transl Sci. 2021 Nov 12;4(6):1818-1834
MV(4;11) 2000, 200, 20, 2 nM 24 hours Assess LSD1 target engagement, Iadademstat showed the highest LSD1 target engagement ACS Pharmacol Transl Sci. 2021 Nov 12;4(6):1818-1834
TF-1a 0.002 to 2000 nM 96 hours Evaluate the effect of Iadademstat on TF-1a cell viability, EC50 in subnanomolar range ACS Pharmacol Transl Sci. 2021 Nov 12;4(6):1818-1834
LNCaP cells 5 nM 96 hours To evaluate KDM1A target engagement, results showed that free KDM1A was reduced by ~80% after treatment with 5 nM ORY-1001 J Biol Chem. 2019 May 17;294(20):8311-8322
MV(4;11) cells 5 nM 96 hours To evaluate KDM1A target engagement, results showed that free KDM1A was reduced by ~80% after treatment with 5 nM ORY-1001 J Biol Chem. 2019 May 17;294(20):8311-8322
THP-1 cells 5 nM 96 hours To evaluate KDM1A target engagement, results showed that free KDM1A was reduced by ~80% after treatment with 5 nM ORY-1001 J Biol Chem. 2019 May 17;294(20):8311-8322
U2OS osteosarcoma cells 50 nM 24 h Inhibition of KDM1A, leading to accumulation of H3K9 methylation and loss of H3K9 acetylation Epigenetics Chromatin. 2023 May 13;16(1):18
A549 lung adenocarcinoma cells 50 nM 24 h Inhibition of KDM1A, leading to accumulation of H3K9 methylation and loss of H3K9 acetylation Epigenetics Chromatin. 2023 May 13;16(1):18
BT-474 cells 10 µmol/L 48 hours Evaluate the inhibitory effect of iadademstat on SOX2 enhancer-driven transcriptional activation, showing a dose-dependent reduction in reporter activity Aging (Albany NY). 2020 Mar 18;12(6):4794-4814
MDA-MB-436 cells 3.98 µmol/L (IC50) 6 days Evaluate the inhibitory effect of iadademstat on CSC-driven mammosphere formation, showing a dose-dependent decrease in mammosphere number Aging (Albany NY). 2020 Mar 18;12(6):4794-4814

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
Rats Sprague-Dawley rats Oral 2.5 μg/kg and 15 μg/kg Single dose or 5 consecutive days To evaluate the pharmacokinetics and pharmacodynamics relationship of ORY-1001, results showed maximum target engagement in PBMCs at 24 h after single dose and 6 h after repeated administration for 5 days, and target inhibition persisted after plasma levels returned to baseline J Biol Chem. 2019 May 17;294(20):8311-8322

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

3.30mL

0.66mL

0.33mL

16.49mL

3.30mL

1.65mL

32.97mL

6.59mL

3.30mL

Dissolving Methods
The prepared working fluid is recommended to be prepared now and used up as soon as possible in a short period of time. The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
 

Historical Records

Categories